View all newsletters
Receive our newsletter – data, insights and analysis delivered to you

Fleet Bioprocessing to Attend the European Gyrolab Seminar, Milan

Fleet Bioprocessing has announced that it will be attending the European Gyrolab Seminar at the Grand Viscount Palace in Milan.

Taking place from 3-4 June, Fleet Bioprocessing will be presenting on the topic of Conjugate quality and its impact on Assay Performance.

The seminar is designed to allow existing Gyrolab users and those who wish to find out more about Gyros Protein Technologies and immunoassay advances to network.

Fleet Bioprocessing offer unrivalled expertise in the development, validation and manufacture of bioconjugates. The company also possesses industry-leading expertise in all aspects of immunoassay design, development and validation and are a certified assay transfer and development partner for the Gyrolab high-throughput immunoassay platform.

If you would like to discuss any aspect of bioconjugation, enzyme-linked immunosorbent assay (ELISA) development or Gyrolab assay development, please contact Fleet Bioprocessing using the contact form on this page.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena